ATXS – astria therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Astria Therapeutics, Inc. (NASDAQ: ATXS) had its price target lowered by analysts at HC Wainwright from $18.00 to $16.00. They now have a "buy" rating on the stock.
Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors [Yahoo! Finance]
Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Form ARS Astria Therapeutics, For: Dec 31
Form DEFA14A Astria Therapeutics,
Form DEF 14A Astria Therapeutics, For: Jun 05
Form 4 Astria Therapeutics, For: Apr 08 Filed by: AGARWAL SUNIL
Form 3 Astria Therapeutics, For: Apr 05 Filed by: AGARWAL SUNIL
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.